A retrospective analysis of 105,000+ patients revealed: 40% lower OSA risk with tirzepatide (Zepbound) or semaglutide (Wegovy) vs non-AOM users Lower OSA incidence: 3.12% vs 12.56% Comparable impact between tirzepatide and semaglutide, with tirzepatide showing a slight edge after 6 months This study highlights the potential for AOMs to address obesity and OSA, supporting broader healthcare value through comorbidity reduction
If Denmark decided to hit back, U.S
Step 2: Talk To Your Doctor Bring a list of your feelings and symptoms Ask if your medication could be playing a role Be honestit helps your provider help you Step 3: Get Support Consider talking to a therapist Reach out to support groups Stay connected with friends and family The Bottom Line: Whats True, Whats Not
Insulin is a hormone that allows sugar (or glucose) to enter cells, where it is used for energy
Problems arise only when its production becomes imbalanced
Soon the cells in our skin that make our pigment, melanocytes, become responsive to this master hormone and bronzing of the skin is observed
